SuperworthUtah Medical Products profit margin UTMD
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 29.0%
- Operating margin, 12 months
- 28.4%
- Net margin on a year earlier
- −3.3 pts
- Peer median
- 6.4%
Over the twelve months to Jun 30, 2026, Utah Medical Products kept 29.0% of its revenue as net profit, with an operating margin of 28.4% and a gross margin of 57.9%.
Five years earlier its net margin was 27.8%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 29.3% | 29.6% | 57.1% |
| FY2024 | 33.9% | 33.2% | 59.0% |
| FY2023 | 33.1% | 33.4% | 59.8% |
| FY2022 | 31.5% | 37.9% | 61.6% |
| FY2021 | 30.1% | 38.5% | 63.0% |
| FY2020 | 25.6% | 32.5% | 60.6% |
| FY2019 | 31.4% | 37.6% | 62.8% |
| FY2018 | 44.2% | 44.5% | 62.6% |
| FY2017 | 20.5% | 45.9% | 63.7% |
| FY2016 | 30.9% | 41.2% | 60.3% |
| FY2015 | 29.5% | 39.0% | 60.2% |
| FY2014 | 27.6% | 39.3% | 60.5% |
| FY2013 | 28.2% | 36.6% | 59.9% |
| FY2012 | 24.5% | 36.6% | 60.9% |
| FY2011 | 19.6% | 31.3% | 59.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 29.0% | −3.3 pts | 28.4% | |
| Q1 FY26 | 28.9% | −4.1 pts | 28.8% | |
| Q4 FY25 | 29.3% | −4.6 pts | 29.6% | |
| Q3 FY25 | 30.1% | −4.5 pts | 30.8% | |
| Q2 FY25 | 32.3% | −1.2 pts | 32.5% | |
| Q1 FY25 | 33.0% | −0.4 pts | 32.8% | |
| Q4 FY24 | 33.9% | +0.8 pts | 33.2% | |
| Q3 FY24 | 34.6% | +1.8 pts | 33.1% | |
| Q2 FY24 | 33.6% | +0.3 pts | 32.7% | |
| Q1 FY24 | 33.4% | +0.7 pts | 33.1% | |
| Q4 FY23 | 33.1% | +1.6 pts | 33.4% | |
| Q3 FY23 | 32.8% | +1.8 pts | 34.8% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Utah Medical Products' size, closest first, today.
| Company | Profit margin |
|---|---|
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| PDEXPro DEX | 17.6% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| KEQUKewaunee Scientific | 3.0% |
| MOVMovado | 6.0% |
| APTAlpha Pro Tech | 6.8% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| Peer median | 6.4% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Utah Medical Products
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.